Fmoc,tBuOEt-Gly-OH*DCHA

Fmoc,tBuOEt-Gly-OH*DCHA is a glycine-based protected amino acid derivative bearing an Fmoc N-protecting group and a tBuOEt ester functionality, supplied as a DCHA salt form that can influence handling, crystallinity, and coupling behavior. The molecule contains a chiral-free amino acid core (glycine) with an activated N-fluorenylmethoxycarbonyl carbamate and an ester-protected carboxyl equivalent, enabling controlled peptide coupling while minimizing side reactions from the free amine or acid. The presence of the bulky tert-butyl ethyl ester motif supports orthogonal deprotection strategies relative to the Fmoc group, while the salt counterion (DCHA) can modulate solubility in common peptide synthesis solvents. The combination of a stable Fmoc-protected amine and an ester-protected carboxyl functionality makes the compound a practical intermediate for protected amino acid synthesis, peptide building block preparation, and downstream conversion to free carboxylic acid or activated peptide fragments.

1. Peptide Synthesis

Fmoc,tBuOEt-Gly-OH*DCHA supports automated and manual peptide assembly by providing an Fmoc-protected glycine residue for N-to-C coupling workflows. The Fmoc carbamate on the amino group enables selective deprotection under base conditions to reveal the glycine nucleophile while keeping the ester-protected carboxyl equivalent protected during chain elongation. The tBuOEt ester can be chosen to remain intact through standard coupling steps, allowing controlled generation of the corresponding carboxyl functionality for subsequent fragment ligation or final deprotection. The DCHA salt form can be used to tune physical properties relevant to weighing accuracy and reproducible reactivity in peptide building block preparation for research and manufacturing.

2. Protected Amino Acids

Fmoc,tBuOEt-Gly-OH*DCHA functions as a protected amino acid intermediate for building block libraries that require orthogonal protection and predictable deprotection sequences. The Fmoc group provides an N-protecting handle compatible with orthogonal strategies, while the tBuOEt ester protects the carboxyl functionality against premature activation or salt formation during intermediate handling. The glycine backbone, lacking a stereocenter, simplifies stereochemical control while focusing attention on protecting-group stability and chemoselective transformations. The DCHA counterion can assist in process design by improving handling characteristics for protected amino acid synthesis and for preparing downstream activated derivatives used in peptide coupling chemistry.

3. Chemical Manufacturing

Fmoc,tBuOEt-Gly-OH*DCHA can be applied in process chemistry and specialty chemical production where protected amino acid intermediates are manufactured for downstream peptide and peptidomimetic workflows. The Fmoc-protected amine and ester-protected carboxyl equivalent are well-suited to controlled manufacturing routes that separate protection, purification, and conversion steps, reducing cross-reactivity from free functional groups. The salt form with DCHA can be leveraged to influence solid-state properties and solvent compatibility, which may be relevant for scalable intermediate preparation and consistent feedstock behavior. The compound's structure aligns with industrial needs for reproducible peptide building block supply, enabling subsequent conversion into coupling-ready fragments and supporting manufacturing of protected amino acid derivatives used across fine chemical synthesis.

4. Peptidomimetics Construction

Fmoc,tBuOEt-Gly-OH*DCHA serves as a glycine-based precursor for peptidomimetic and constrained scaffold construction where controlled N-protection and carboxyl equivalent management are required. The Fmoc carbamate can be removed to generate a coupling-ready amino component, while the protected carboxyl functionality supports formation of amide linkages or further derivatization into activated intermediates for scaffold elaboration. The absence of stereochemistry at the glycine center can simplify incorporation into diverse analog series used for structure-activity relationship studies and molecular design campaigns. The DCHA salt form can aid in preparing consistent intermediate batches for subsequent functional group transformations that extend amino acid chemistry into peptidomimetic synthesis.

1. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

2. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

3. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes